Key Events This Week
28 Sep: Stock opens week at Rs.173.95, down 2.33% amid Sensex decline
29 Sep: Recovery begins with 1.72% gain to Rs.176.95 despite Sensex fall
30 Sep: Continued gains of 1.47% to Rs.179.55 on strong volume
01 Oct: New 52-week and all-time high at Rs.199.10 on record volume and turnover
28 September 2026: Week Opens on a Weak Note
Gujarat Kidney & Super Speciality Ltd started the week at Rs.173.95, down 2.33% from the previous close, mirroring the broader market weakness as the Sensex declined 1.60% to 34,788.97. The stock’s volume was moderate at 24,067 shares, reflecting cautious investor sentiment amid a negative market backdrop. This initial dip set the stage for a recovery rally in the following sessions.
29 September 2026: Early Recovery Despite Market Pressure
The stock rebounded with a 1.72% gain to close at Rs.176.95, supported by increased volume of 35,325 shares. This recovery was notable as the Sensex continued to decline by 0.48%, closing at 34,621.52. The stock’s relative strength suggested emerging investor interest and resilience against the broader market downtrend.
30 September 2026: Steady Gains on Strong Volume
Gujarat Kidney & Super Speciality Ltd extended its gains by 1.47% to Rs.179.55, buoyed by a significant jump in volume to 1,15,938 shares. The Sensex marginally declined by 0.17% to 34,564.37. The stock’s steady advance ahead of the week’s close indicated growing momentum, supported by positive technical signals and improving market sentiment towards the company.
Momentum building strong! This Mid Cap from NBFC is on our MomentumNow radar. Other investors are catching on – will you join?
- - Building momentum strength
- - Investor interest growing
- - Limited time advantage
1 October 2026: Record Highs on Exceptional Volume and Turnover
The stock surged 8.16% intraday to close at Rs.194.20, hitting a new 52-week and all-time high of Rs.199.10. This rally was accompanied by extraordinary trading activity, with volume reaching 13,44,700 shares and a traded value of approximately ₹534.19 crores. The stock opened at Rs.180.10, gapping up 11.14% from the previous close, signalling strong overnight buying interest.
Intraday volatility was high at 5.22%, with the stock touching a peak of Rs.209.80 before settling near Rs.198.00 by midday. Despite the broader market’s continued weakness, with the Sensex falling 0.99% to 34,221.41, Gujarat Kidney & Super Speciality Ltd outperformed its sector peers by 11.75% and the Sensex by 12.0%, underscoring its robust relative strength.
Technical indicators remain favourable, with the stock trading above all major moving averages (5-day, 20-day, 50-day, 100-day, and 200-day), supported by bullish MACD and Bollinger Bands signals. However, the weekly RSI shows some bearish tendencies, suggesting potential short-term caution despite the strong momentum.
Financially, the company reported strong growth with net sales rising 159.07% to ₹64.87 crores over the last six months and profit after tax increasing 66.99% to ₹10.22 crores. The company maintains a low debt profile and a robust return on capital employed of 26.45%, though return on equity remains weak at 0.0%. Institutional holdings are modest at 5.44%, and delivery volumes showed a slight decline, indicating some short-term trading activity amid the surge.
Daily Price Comparison: Gujarat Kidney & Super Speciality Ltd vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-09-28 | Rs.173.95 | -2.33% | 34,788.97 | -1.60% |
| 2026-09-29 | Rs.176.95 | +1.72% | 34,621.52 | -0.48% |
| 2026-09-30 | Rs.179.55 | +1.47% | 34,564.37 | -0.17% |
| 2026-10-01 | Rs.194.20 | +8.16% | 34,221.41 | -0.99% |
Gujarat Kidney & Super Speciality Ltd or something better? Our SwitchER feature analyzes this micro-cap stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Key Takeaways
Positive Signals: Gujarat Kidney & Super Speciality Ltd demonstrated strong price momentum with a 9.04% weekly gain, significantly outperforming the Sensex’s 3.20% decline. The stock’s new 52-week and all-time high of Rs.199.10, supported by record volume and turnover, reflects robust investor interest and technical strength. Financial results showing substantial revenue and profit growth underpin the rally, alongside a solid return on capital employed and low leverage.
Cautionary Notes: Despite the strong momentum, the stock’s weekly RSI indicates some bearish pressure, suggesting potential short-term volatility. The downgrade in Mojo Grade from Buy to Hold signals a more cautious analyst stance, likely due to elevated valuation multiples such as a trailing P/E of 89x and EV/EBITDA of 51.23x. Declining delivery volumes amid rising trade volumes hint at increased short-term trading activity rather than sustained accumulation, which could introduce price fluctuations.
Conclusion
Gujarat Kidney & Super Speciality Ltd’s performance over the week ending 1 October 2026 highlights a compelling story of resilience and growth within the hospital sector. The stock’s 9.04% gain and new all-time highs amid a declining Sensex underscore its relative strength and market appeal. Supported by strong financial metrics and positive technical indicators, the stock has attracted significant trading interest and institutional participation. However, investors should remain mindful of valuation levels and potential short-term volatility as indicated by technical signals and delivery volume trends. Overall, Gujarat Kidney & Super Speciality Ltd stands out as a micro-cap stock with notable momentum and operational progress in a challenging market environment.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
